[A critical evaluation of the cardiac arrhythmia suppression trial study].
Huang
W
W
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017327:Clinical Trials, Phase IV as Topic; D016700:Encainide / Q000627:therapeutic use; D005424:Flecainide / Q000627:therapeutic use; D006801:Humans
D000889:Anti-Arrhythmia Agents; D005424:Flecainide; D016700:Encainide